跳至主要内容
临床试验/EUCTR2008-005206-39-IT
EUCTR2008-005206-39-IT进行中(未招募)不适用

Pilot Study: Iron-chelating treatment in patients with Neurodegeneration with Brain Iron Accumulation (NBIA). - ND

AZIENDA OSPEDALIERA OSPEDALI GALLIERA0 个研究点开始时间: 2008年11月26日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients aged ≥ 18 years affected from a neurological de generation with brain iron accumulation documented by RMI and who do not present sistemyc iron overload escluded by RMI and/or SQUID, MID, Needle Liver Biopsy. Patients who signed and witnessed written informed consent.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Patients unable to undergo MRI. Patients with serum creatinine > 1.5 mg/dl. History of malignancy of any organ system. Patients with cardiovascolar, renal and liver deseases that do not allow the administration of the study drug. Hypersensitivity to deferiprone
  • Patients unwilling or unable to comply with the protocol. Pregnant or breastfeeding women are not elegible to partecipate in the study

研究者

发起方
AZIENDA OSPEDALIERA OSPEDALI GALLIERA

相似试验